| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.5M | -16.0% |
| SG&A Expense | $8.1M | -14.9% |
| Operating Income | -$32.6M | +15.7% |
| Pre-tax Income | -$41.3M | +4.5% |
| Income Tax | $0 | — |
| Net Income | -$41.3M | +4.5% |
| EPS (Basic) | -$0.89 | +13.6% |
| EPS (Diluted) | -$0.89 | +13.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -79.3% |
| Current Assets | $43.7M | -38.8% |
| Total Assets | $68.2M | -37.7% |
| Current Liabilities | $10.8M | +10.9% |
| Total Liabilities | $12.1M | -1.4% |
| Stockholders' Equity | $56.1M | -42.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.0M | +26.4% |
| Capital Expenditures | $269K | +5280.0% |
| Investing Cash Flow | -$23.3M | -208.0% |
| Financing Cash Flow | $62.2M | +0.0% |
| Free Cash Flow | -$27.3M | +25.7% |